Skip to content

The effect of doxium on retial thickness in diabetic patients

The effect of oral calcium dobisulate (doxium) on macular thickness in diabetic retinopathy and clinicaly significant macular edema(CSME)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012091610852N1
Enrollment
40
Registered
2013-04-21
Start date
2012-07-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabets melitus. Diabetic retinopathy

Interventions

Intervention 1: calcium dobisulate (doxium) capsules 500 mg,oraly , three times in one day for three months. Intervention 2: Placebo capsules, orally ,three times daily for three months.
Treatment - Drugs
Placebo
calcium dobisulate (doxium) capsules 500 mg,oraly , three times in one day for three months
Placebo capsules, orally ,three times daily for three months.

Sponsors

Ahvaz Jundishapur University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria : All patients with non prolifrative diabetic retinopathy and clinical significant macular edema refered to retinal clinic emam khomini hospital ,, ***Exclusion critreria ::History of previous treatment for clinical significant macular edema such macular laser and intra viterus avastin injection ;Posterior segment trauma ;The need for subsequent surgery of the eye, such as cataract surgery or vitreoretinal ;Clinical evaluation is not possible or where 0CT or FA Like intense opacity media; despite previous pathology such as retinal vascular occlusion, AMD...; History of previous intraocular surgery; Patients with visual acuity less than 1/10

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Macular thickness. Timepoint: befor and 3 month of treatment. Method of measurement: OCT.

Secondary

MeasureTime frame
Visual acuity. Timepoint: before and 3 month after treatment. Method of measurement: snelen chart.;Intra ocular pressure. Timepoint: before and 3 month after treatment. Method of measurement: goldman tonometry.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAkbar Takhtaeayan

Ahvaz Jundishapur University of Medical Sciences

akbart79@yahoo.com+98 61 1373 8383

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026